Expect Equity LLC Buys New Holdings in Viemed Healthcare, Inc. $VMD

Expect Equity LLC purchased a new position in shares of Viemed Healthcare, Inc. (NASDAQ:VMD) during the second quarter, Holdings Channel.com reports. The institutional investor purchased 212,721 shares of the company’s stock, valued at approximately $2,425,000. Viemed Healthcare makes up approximately 1.6% of Expect Equity LLC’s portfolio, making the stock its 27th biggest holding.

Other institutional investors and hedge funds have also recently bought and sold shares of the company. State of Alaska Department of Revenue bought a new position in shares of Viemed Healthcare during the 4th quarter worth about $25,000. Kemnay Advisory Services Inc. bought a new stake in Viemed Healthcare in the fourth quarter valued at about $46,000. Quarry LP acquired a new position in Viemed Healthcare in the third quarter worth about $48,000. Globeflex Capital L P acquired a new position in Viemed Healthcare in the second quarter worth about $86,000. Finally, AQR Capital Management LLC bought a new position in Viemed Healthcare during the first quarter worth about $90,000. Institutional investors own 74.24% of the company’s stock.

Viemed Healthcare Trading Up 0.1%

Shares of VMD stock opened at $9.10 on Wednesday. The company has a market capitalization of $346.62 million, a P/E ratio of 25.28 and a beta of 1.10. Viemed Healthcare, Inc. has a 12-month low of $6.05 and a 12-month high of $12.61. The company has a quick ratio of 1.02, a current ratio of 1.13 and a debt-to-equity ratio of 0.04. The firm has a 50-day moving average price of $10.92 and a 200 day moving average price of $9.89.

Viemed Healthcare (NASDAQ:VMD) last issued its quarterly earnings data on Monday, August 3rd. The company reported $0.07 earnings per share for the quarter, missing the consensus estimate of $0.12 by ($0.05). The firm had revenue of $78.10 million for the quarter, compared to the consensus estimate of $78.00 million. Viemed Healthcare had a return on equity of 10.16% and a net margin of 4.81%. Research analysts forecast that Viemed Healthcare, Inc. will post 0.42 earnings per share for the current fiscal year.

Insider Buying and Selling

In related news, insider William Frazier sold 10,000 shares of the stock in a transaction that occurred on Thursday, June 25th. The stock was sold at an average price of $11.72, for a total transaction of $117,200.00. Following the sale, the insider directly owned 73,214 shares in the company, valued at $858,068.08. This represents a 12.02% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, Director Timothy Smokoff sold 20,000 shares of the firm’s stock in a transaction on Wednesday, June 24th. The shares were sold at an average price of $11.50, for a total value of $230,000.00. Following the sale, the director directly owned 75,518 shares of the company’s stock, valued at $868,457. This represents a 20.94% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. 20.60% of the stock is owned by corporate insiders.

Wall Street Analyst Weigh In

A number of equities research analysts have weighed in on VMD shares. Wall Street Zen downgraded Viemed Healthcare from a “strong-buy” rating to a “buy” rating in a report on Saturday, August 15th. Freedom Capital cut Viemed Healthcare from a “strong-buy” rating to a “hold” rating in a report on Wednesday, August 5th. Barrington Research started coverage on Viemed Healthcare in a research report on Monday. They set an “outperform” rating and a $14.00 target price for the company. Finally, Weiss Ratings lowered Viemed Healthcare from a “buy (b-)” rating to a “hold (c+)” rating in a research note on Monday, August 17th. One investment analyst has rated the stock with a Buy rating and three have assigned a Hold rating to the stock. According to MarketBeat, the stock currently has an average rating of “Hold” and a consensus price target of $14.00.

About Viemed Healthcare

Viemed Healthcare, Inc (NASDAQ: VMD) is a provider of home-based respiratory therapy services, specializing in the management of patients requiring long-term mechanical ventilation and pulmonary support. The company’s offerings encompass invasive and noninvasive ventilation, airway clearance therapies, cough assist devices, and supplemental oxygen. Viemed combines durable medical equipment with clinical care, delivering tailored respiratory treatment plans that are overseen by licensed respiratory therapists and registered nurses.

Founded in the early 2010s and headquartered in Birmingham, Alabama, Viemed has grown its footprint to serve patients across multiple states in the United States.